Therefore, the purpose of this study is to analyze how structural and functional alterations of the visual pathway progress at 27-month follow-up in a population of cognitively healthy subjects, without neurological or ophthalmological diseases, but with significant genetic risk of developing AD (family history positive and carriers of ApoE ε4+). This evidence concerns the gene APOE and Alzheimer disease.